BIOGEN (DENMARK) A/S: Financial statements 2022
CVR: 21682977
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 307,509,784 and a net result of DKK 8,438,232 compared with DKK 7,551,843 the year before. That is an increase of 18.4% compared with the year before. The profit margin was 2.7%. Equity in the 2022 report amounted to DKK 130,457,003. The solvency ratio was 81.4%. The company had 24 employees in the financial year.
- Revenue
- DKK 307,509,784
- Gross Profit
- DKK 47,038,333
- Profit/Loss
- DKK 8,438,232
- Equity
- DKK 130,457,003
- Total Assets
- DKK 160,344,125
- Employees
- 24
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 307.5 mio. | 47 mio. | 8.4 mio. | 130.5 mio. | 24 |
| 2021 | 259.7 mio. | 45.9 mio. | 7.6 mio. | 122 mio. | 22 |
| 2020 | 303.4 mio. | 51.7 mio. | 10.1 mio. | 114.5 mio. | 25 |
| 2019 | 324.9 mio. | 49.6 mio. | 12.3 mio. | 104.3 mio. | 27 |
| 2018 | 355 mio. | 53.4 mio. | 12.5 mio. | 92.1 mio. | 24 |
Official annual report
Keep an eye on BIOGEN (DENMARK) A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 1, 2022, Louise Hammerich has joined the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2022, Tashia Susana Lentz has left the board of directors of BIOGEN (DENMARK) A/S.
As of December 1, 2022, Louise Hammerich is registered as adm. dir. of BIOGEN (DENMARK) A/S.
As of December 1, 2022, Tashia Susana Lentz has stepped down as adm. dir. of BIOGEN (DENMARK) A/S.
As of September 1, 2022, Sergio Ferreira da Silva Teixeira has joined the board of directors of BIOGEN (DENMARK) A/S.
As of August 31, 2022, Ulf Johan Ström has left the board of directors of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2021. Revenue came to DKK 259,684,984, and the net result was DKK 7,551,843.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 13 employees (2026). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.